Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Joyce Lee

Concepts (354)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Diseases, Interstitial
66
2025
660
12.870
 Why?
Idiopathic Pulmonary Fibrosis
63
2026
691
11.270
 Why?
Arthritis, Rheumatoid
25
2025
1170
4.730
 Why?
Scleroderma, Systemic
10
2025
123
2.420
 Why?
Immunosuppressive Agents
9
2025
834
2.040
 Why?
Connective Tissue Diseases
9
2021
84
1.690
 Why?
Lung
28
2025
4089
1.640
 Why?
Cryptogenic Organizing Pneumonia
2
2025
20
1.640
 Why?
Mucin-5B
5
2025
234
1.530
 Why?
Vital Capacity
19
2025
290
1.520
 Why?
Autoimmune Diseases
11
2025
465
1.470
 Why?
Tomography, X-Ray Computed
28
2025
2754
1.470
 Why?
Adrenal Cortex Hormones
4
2025
480
1.380
 Why?
Disease Progression
14
2025
2847
1.370
 Why?
Gastroesophageal Reflux
5
2020
236
1.230
 Why?
Rheumatic Diseases
5
2024
97
1.190
 Why?
Pulmonary Fibrosis
10
2025
393
1.150
 Why?
Prognosis
24
2025
4312
1.130
 Why?
Humans
135
2026
144667
1.020
 Why?
Myositis
5
2025
57
0.990
 Why?
Alveolitis, Extrinsic Allergic
6
2022
93
0.970
 Why?
Respiratory Aspiration
4
2020
32
0.920
 Why?
Biomarkers
12
2025
4261
0.890
 Why?
Telomere
3
2025
290
0.870
 Why?
Aged
54
2026
25955
0.850
 Why?
Middle Aged
58
2026
35971
0.850
 Why?
Idiopathic Interstitial Pneumonias
4
2019
44
0.840
 Why?
Quality of Life
4
2024
3183
0.810
 Why?
Diagnosis, Differential
10
2025
1501
0.770
 Why?
Telomerase
2
2023
249
0.750
 Why?
Carcinoma, Hepatocellular
5
2025
370
0.740
 Why?
Pulmonary Surfactants
1
2023
103
0.740
 Why?
Histamine H2 Antagonists
2
2013
23
0.730
 Why?
Glucocorticoids
3
2024
528
0.720
 Why?
Matrix Metalloproteinase 7
1
2021
25
0.700
 Why?
Respiratory Function Tests
11
2025
541
0.690
 Why?
Proton Pump Inhibitors
2
2013
109
0.680
 Why?
Male
71
2026
72431
0.680
 Why?
Proteomics
3
2025
1183
0.650
 Why?
Rheumatology
5
2024
133
0.640
 Why?
Lung Transplantation
10
2025
329
0.630
 Why?
Female
70
2026
78304
0.620
 Why?
Cellular Senescence
1
2021
223
0.560
 Why?
Telomere Shortening
3
2025
19
0.540
 Why?
Genetic Predisposition to Disease
3
2026
2350
0.540
 Why?
Liver Neoplasms
5
2025
777
0.530
 Why?
Prospective Studies
13
2025
7994
0.520
 Why?
Severity of Illness Index
10
2025
2922
0.500
 Why?
Abatacept
3
2025
56
0.490
 Why?
Dyspnea
5
2023
250
0.480
 Why?
Patient Satisfaction
2
2021
707
0.470
 Why?
Forecasting
1
2017
391
0.460
 Why?
Survival Rate
11
2025
2089
0.460
 Why?
Risk Assessment
10
2021
3729
0.450
 Why?
Longitudinal Studies
8
2017
2942
0.410
 Why?
Cohort Studies
13
2025
5957
0.410
 Why?
Azathioprine
2
2024
44
0.390
 Why?
Patient Education as Topic
2
2016
771
0.390
 Why?
Pulmonary Diffusing Capacity
5
2020
78
0.380
 Why?
Precision Medicine
1
2017
454
0.380
 Why?
Early Diagnosis
2
2025
249
0.370
 Why?
Hypertension, Pulmonary
3
2022
1948
0.360
 Why?
Rituximab
2
2024
211
0.360
 Why?
Pepsin A
1
2011
18
0.350
 Why?
Antirheumatic Agents
4
2024
304
0.350
 Why?
Comprehensive Health Care
1
2011
22
0.340
 Why?
Fundoplication
1
2011
52
0.340
 Why?
Sleep Apnea, Obstructive
1
2015
300
0.330
 Why?
Veterans
4
2023
1614
0.320
 Why?
Carbon Monoxide
4
2019
82
0.310
 Why?
Bronchoalveolar Lavage Fluid
2
2011
630
0.310
 Why?
Endotoxins
1
2010
218
0.300
 Why?
Forced Expiratory Volume
4
2025
448
0.300
 Why?
Sirolimus
1
2011
280
0.300
 Why?
Proportional Hazards Models
7
2024
1322
0.300
 Why?
Phenotype
6
2025
3147
0.290
 Why?
Anti-Bacterial Agents
1
2019
1928
0.280
 Why?
Walk Test
2
2025
80
0.280
 Why?
United States
17
2025
16018
0.270
 Why?
Biopsy
5
2025
1079
0.270
 Why?
Retrospective Studies
16
2024
17149
0.270
 Why?
Emphysema
2
2022
100
0.260
 Why?
Mycophenolic Acid
3
2024
120
0.260
 Why?
Acute Lung Injury
1
2010
301
0.260
 Why?
Lung Diseases
3
2020
781
0.250
 Why?
Risk Factors
11
2026
10796
0.250
 Why?
Comorbidity
5
2015
1652
0.250
 Why?
Autoantibodies
2
2015
1505
0.230
 Why?
Prevalence
5
2022
2839
0.230
 Why?
Immunotherapy
3
2025
662
0.230
 Why?
Cancer-Associated Fibroblasts
1
2025
23
0.230
 Why?
Depression
1
2015
1561
0.230
 Why?
Predictive Value of Tests
4
2017
2117
0.230
 Why?
Thoracic Surgery, Video-Assisted
1
2025
48
0.220
 Why?
Pulmonologists
1
2025
14
0.220
 Why?
Pyridones
2
2024
201
0.220
 Why?
Yttrium Radioisotopes
2
2023
64
0.220
 Why?
Mutation
3
2023
4081
0.220
 Why?
Antineoplastic Agents, Phytogenic
1
2026
176
0.220
 Why?
Paclitaxel
1
2026
256
0.220
 Why?
Sex Factors
4
2020
2104
0.220
 Why?
Aged, 80 and over
10
2024
8284
0.210
 Why?
Case-Control Studies
6
2021
3603
0.210
 Why?
Endothelium, Vascular
1
2010
949
0.200
 Why?
Spirometry
3
2025
231
0.200
 Why?
Biopsy, Needle
3
2019
184
0.200
 Why?
Chronic Disease
6
2020
1810
0.200
 Why?
Exercise Tolerance
1
2025
282
0.200
 Why?
Pulmonary Emphysema
2
2025
275
0.200
 Why?
Blood Proteins
1
2025
230
0.200
 Why?
Sputum
1
2025
308
0.190
 Why?
Fatty Liver
1
2025
250
0.190
 Why?
Urinary Bladder Neoplasms
1
2026
260
0.190
 Why?
Treatment Outcome
8
2025
11735
0.190
 Why?
Polychlorinated Dibenzodioxins
1
2022
10
0.190
 Why?
T-Lymphocytes, Regulatory
1
2025
394
0.190
 Why?
Fibrosis
3
2022
547
0.180
 Why?
Transforming Growth Factor beta
1
2025
475
0.180
 Why?
Indoles
2
2024
504
0.180
 Why?
Genotype
2
2025
1847
0.180
 Why?
Recurrence
1
2025
1136
0.180
 Why?
Adult
19
2025
40489
0.180
 Why?
Genetic Testing
1
2025
480
0.180
 Why?
Self Care
2
2017
389
0.170
 Why?
Monocytes
2
2021
536
0.170
 Why?
Organizational Objectives
1
2021
66
0.170
 Why?
Incidence
5
2023
2892
0.170
 Why?
Genetic Markers
1
2022
332
0.170
 Why?
Nursing Research
1
2021
49
0.170
 Why?
Societies, Medical
5
2025
890
0.160
 Why?
Chemoembolization, Therapeutic
1
2021
88
0.160
 Why?
Kaplan-Meier Estimate
5
2017
967
0.160
 Why?
Smoking
3
2024
1467
0.160
 Why?
Patient Outcome Assessment
1
2021
132
0.160
 Why?
Chemokine CX3CL1
1
2020
25
0.160
 Why?
Immunohistochemistry
3
2019
1705
0.160
 Why?
Disease Models, Animal
1
2010
4539
0.150
 Why?
Survival Analysis
3
2012
1370
0.150
 Why?
Models, Organizational
1
2020
143
0.150
 Why?
Disease Management
4
2018
650
0.150
 Why?
Myositis, Inclusion Body
1
2019
11
0.150
 Why?
Graft Rejection
2
2020
512
0.150
 Why?
Radiography
2
2011
848
0.140
 Why?
Wnt-5a Protein
1
2018
24
0.140
 Why?
Gain of Function Mutation
1
2018
34
0.140
 Why?
Body Weight
1
2022
968
0.140
 Why?
Immunity, Innate
1
2024
843
0.140
 Why?
Ambulatory Care Facilities
1
2020
267
0.140
 Why?
Hypoxia
1
2025
1193
0.130
 Why?
Signal Transduction
2
2023
5185
0.130
 Why?
Focus Groups
2
2020
566
0.130
 Why?
Randomized Controlled Trials as Topic
1
2024
1742
0.130
 Why?
International Cooperation
1
2017
197
0.130
 Why?
Weight Loss
1
2022
839
0.120
 Why?
Myofibroblasts
1
2018
142
0.120
 Why?
Amino Acyl-tRNA Synthetases
1
2016
32
0.120
 Why?
Health Status Indicators
1
2017
167
0.120
 Why?
Women's Health
1
2018
307
0.120
 Why?
Patient-Centered Care
1
2021
545
0.120
 Why?
Extracellular Vesicles
1
2018
171
0.120
 Why?
Tomography Scanners, X-Ray Computed
1
2015
21
0.110
 Why?
Practice Patterns, Physicians'
1
2025
1360
0.110
 Why?
Acute Disease
3
2016
1029
0.110
 Why?
Follow-Up Studies
4
2019
5414
0.110
 Why?
Sarcoidosis
1
2017
163
0.110
 Why?
Cause of Death
1
2017
464
0.110
 Why?
Pulmonary Medicine
1
2015
78
0.110
 Why?
Antibiotic Prophylaxis
1
2016
134
0.110
 Why?
Sleep Wake Disorders
1
2018
308
0.110
 Why?
Nails
1
2014
13
0.100
 Why?
Hyperpigmentation
1
2014
27
0.100
 Why?
Hospitalization
1
2025
2446
0.100
 Why?
Bronchodilator Agents
1
2015
184
0.100
 Why?
Body Mass Index
1
2022
2419
0.100
 Why?
Oxygen Inhalation Therapy
1
2016
181
0.100
 Why?
Laparoscopy
1
2018
477
0.100
 Why?
Gene Expression Profiling
1
2020
1766
0.100
 Why?
Arsenic
1
2014
65
0.100
 Why?
Interleukin-13
1
2014
144
0.100
 Why?
Diagnostic Imaging
1
2016
341
0.100
 Why?
Age Factors
3
2019
3329
0.100
 Why?
Keratin-18
1
2012
12
0.100
 Why?
Counseling
1
2016
405
0.090
 Why?
Cystic Fibrosis
1
2023
1166
0.090
 Why?
Autoimmunity
2
2015
930
0.090
 Why?
Maternal Exposure
1
2014
185
0.090
 Why?
Interviews as Topic
1
2016
905
0.090
 Why?
Microspheres
2
2023
142
0.090
 Why?
Fatigue
1
2014
363
0.090
 Why?
Sjogren's Syndrome
2
2024
37
0.090
 Why?
Age Distribution
3
2019
402
0.090
 Why?
Time Factors
2
2024
7140
0.080
 Why?
Dermatitis, Atopic
1
2014
323
0.080
 Why?
Algorithms
2
2016
1844
0.080
 Why?
Everolimus
1
2011
112
0.080
 Why?
Epithelial Cells
2
2014
1106
0.080
 Why?
Programmed Cell Death 1 Receptor
2
2023
264
0.080
 Why?
Tumor Microenvironment
2
2025
729
0.080
 Why?
Sodium-Potassium-Exchanging ATPase
1
2010
54
0.080
 Why?
Animals
7
2025
37948
0.080
 Why?
Goals
1
2011
184
0.080
 Why?
Fetus
1
2014
800
0.080
 Why?
Leukocytes
2
2025
294
0.070
 Why?
Delphi Technique
2
2022
330
0.070
 Why?
Alveolar Epithelial Cells
1
2010
120
0.070
 Why?
Singapore
2
2021
27
0.070
 Why?
Health Status
1
2014
834
0.070
 Why?
Sensitivity and Specificity
1
2013
1995
0.070
 Why?
Virus Diseases
1
2011
218
0.070
 Why?
Qualitative Research
1
2016
1668
0.070
 Why?
Syndrome
2
2022
379
0.070
 Why?
Models, Statistical
1
2012
677
0.070
 Why?
Proto-Oncogene Proteins c-akt
1
2010
435
0.070
 Why?
Multivariate Analysis
2
2025
1537
0.060
 Why?
DNA
1
2014
1447
0.060
 Why?
Pulmonary Alveoli
2
2025
383
0.060
 Why?
Antibodies, Monoclonal
1
2014
1505
0.060
 Why?
Cell Membrane
1
2010
706
0.060
 Why?
Micelles
1
2026
40
0.060
 Why?
Internationality
2
2017
154
0.060
 Why?
Japan
1
2026
145
0.060
 Why?
France
1
2025
40
0.060
 Why?
Mass Screening
2
2024
1348
0.060
 Why?
Pulmonary Surfactant-Associated Protein D
1
2025
31
0.060
 Why?
Promoter Regions, Genetic
2
2021
1246
0.060
 Why?
Methotrexate
2
2021
231
0.060
 Why?
Logistic Models
2
2025
2114
0.060
 Why?
Genetic Loci
1
2026
260
0.050
 Why?
Cyclophosphamide
1
2025
265
0.050
 Why?
Mixed Connective Tissue Disease
1
2024
10
0.050
 Why?
Pandemics
2
2024
1700
0.050
 Why?
Prednisone
2
2019
221
0.050
 Why?
Sex Distribution
2
2015
386
0.050
 Why?
Mice
3
2025
18261
0.050
 Why?
Professional Practice Gaps
1
2023
15
0.050
 Why?
Demography
1
2024
287
0.050
 Why?
Adaptive Immunity
1
2024
169
0.050
 Why?
Chromosome Deletion
1
2023
124
0.050
 Why?
CD3 Complex
1
2023
111
0.050
 Why?
Agent Orange
1
2022
3
0.050
 Why?
2,4,5-Trichlorophenoxyacetic Acid
1
2022
3
0.050
 Why?
Palliative Care
1
2011
1011
0.050
 Why?
2,4-Dichlorophenoxyacetic Acid
1
2022
14
0.050
 Why?
CTLA-4 Antigen
1
2023
105
0.050
 Why?
Antibody Formation
1
2024
291
0.050
 Why?
Respiratory Mucosa
1
2025
322
0.040
 Why?
Exome
1
2023
227
0.040
 Why?
Whole Genome Sequencing
1
2023
184
0.040
 Why?
Probability
1
2022
309
0.040
 Why?
Patient Reported Outcome Measures
1
2025
496
0.040
 Why?
Administration, Intravenous
1
2021
170
0.040
 Why?
Double-Blind Method
1
2025
2033
0.040
 Why?
Leukocytes, Mononuclear
1
2023
572
0.040
 Why?
Evidence-Based Medicine
1
2024
732
0.040
 Why?
Family
1
2025
685
0.040
 Why?
Bayes Theorem
1
2022
426
0.040
 Why?
CX3C Chemokine Receptor 1
1
2020
20
0.040
 Why?
Total Lung Capacity
1
2019
29
0.040
 Why?
Pilot Projects
1
2025
1886
0.040
 Why?
Allografts
1
2020
150
0.040
 Why?
Immunologic Factors
1
2022
259
0.040
 Why?
Drug Discovery
1
2020
153
0.040
 Why?
Antibodies, Viral
1
2024
672
0.040
 Why?
Genome-Wide Association Study
1
2026
1374
0.040
 Why?
Mice, Inbred C57BL
1
2010
5967
0.040
 Why?
Safety
1
2021
356
0.040
 Why?
Cross-Sectional Studies
2
2025
5870
0.040
 Why?
Fibroblasts
1
2025
1019
0.040
 Why?
Ireland
1
2019
32
0.040
 Why?
Embolization, Therapeutic
1
2021
241
0.040
 Why?
Dermatomyositis
1
2019
24
0.040
 Why?
Insulin
1
2010
2502
0.040
 Why?
Echocardiography
1
2022
644
0.040
 Why?
Polymorphism, Single Nucleotide
1
2026
2137
0.040
 Why?
Rare Diseases
1
2019
115
0.030
 Why?
Combined Modality Therapy
1
2021
1268
0.030
 Why?
Intention to Treat Analysis
1
2018
79
0.030
 Why?
Hydrogen-Ion Concentration
1
2020
562
0.030
 Why?
National Heart, Lung, and Blood Institute (U.S.)
1
2018
103
0.030
 Why?
Behavior
1
2018
90
0.030
 Why?
Education
1
2018
105
0.030
 Why?
United Kingdom
1
2019
337
0.030
 Why?
Morbidity
1
2018
322
0.030
 Why?
Sleep Apnea Syndromes
1
2018
96
0.030
 Why?
Medicare
1
2023
899
0.030
 Why?
CD8-Positive T-Lymphocytes
1
2023
915
0.030
 Why?
Linear Models
1
2019
845
0.030
 Why?
Registries
1
2025
2392
0.030
 Why?
Antibodies, Antinuclear
1
2016
62
0.030
 Why?
Comprehension
1
2018
182
0.030
 Why?
Muscle Strength
1
2019
330
0.030
 Why?
Flow Cytometry
1
2020
1154
0.030
 Why?
Odds Ratio
1
2018
1076
0.030
 Why?
California
1
2017
471
0.030
 Why?
Gene Expression
1
2020
1476
0.030
 Why?
Evaluation Studies as Topic
1
2015
164
0.030
 Why?
Global Health
1
2018
401
0.030
 Why?
Pneumonia, Aspiration
1
2015
16
0.030
 Why?
Vaccination
1
2024
1419
0.030
 Why?
Monitoring, Physiologic
1
2017
288
0.030
 Why?
Recovery of Function
1
2019
715
0.030
 Why?
Bronchiolitis Obliterans
1
2015
61
0.030
 Why?
Regression Analysis
1
2017
998
0.030
 Why?
Sampling Studies
1
2014
98
0.030
 Why?
San Francisco
1
2014
60
0.030
 Why?
Chicago
1
2014
62
0.030
 Why?
Europe
1
2015
419
0.030
 Why?
Neck
1
2014
108
0.030
 Why?
Endothelial Cells
1
2020
864
0.020
 Why?
Patient Acuity
1
2013
47
0.020
 Why?
Texas
1
2014
271
0.020
 Why?
Mice, SCID
1
2014
368
0.020
 Why?
Observational Studies as Topic
1
2013
131
0.020
 Why?
Enzyme Inhibitors
1
2016
820
0.020
 Why?
Protein Kinase Inhibitors
1
2019
971
0.020
 Why?
Developing Countries
1
2014
317
0.020
 Why?
Surveys and Questionnaires
1
2025
6041
0.020
 Why?
Young Adult
2
2022
14122
0.020
 Why?
Endoplasmic Reticulum Stress
1
2012
118
0.020
 Why?
Torque teno virus
1
2011
1
0.020
 Why?
Academic Medical Centers
1
2014
545
0.020
 Why?
DNA Virus Infections
1
2011
3
0.020
 Why?
Cells, Cultured
1
2018
4110
0.020
 Why?
Up-Regulation
1
2014
848
0.020
 Why?
Molecular Targeted Therapy
1
2014
437
0.020
 Why?
Pulmonary Disease, Chronic Obstructive
1
2018
919
0.020
 Why?
Microarray Analysis
1
2011
116
0.020
 Why?
Mass Spectrometry
1
2014
743
0.020
 Why?
Models, Theoretical
1
2014
578
0.020
 Why?
Colorado
1
2020
4558
0.020
 Why?
Subcellular Fractions
1
2010
73
0.020
 Why?
GTPase-Activating Proteins
1
2010
81
0.020
 Why?
Body Fluids
1
2010
71
0.020
 Why?
Practice Guidelines as Topic
1
2017
1569
0.020
 Why?
rab GTP-Binding Proteins
1
2010
76
0.020
 Why?
Adolescent
2
2022
22409
0.020
 Why?
Reproducibility of Results
1
2017
3414
0.020
 Why?
Inflammation
1
2020
2870
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2011
751
0.020
 Why?
Models, Biological
1
2016
1811
0.020
 Why?
Protein Transport
1
2010
437
0.020
 Why?
Phosphatidylinositol 3-Kinases
1
2010
380
0.020
 Why?
Polymerase Chain Reaction
1
2011
1047
0.020
 Why?
Sequence Analysis, DNA
1
2011
828
0.020
 Why?
Telemedicine
1
2017
957
0.020
 Why?
Cattle
1
2010
975
0.020
 Why?
Asthma
1
2018
1774
0.020
 Why?
Respiratory Tract Infections
1
2011
395
0.020
 Why?
Rats, Sprague-Dawley
1
2010
2521
0.010
 Why?
Apoptosis
1
2012
2397
0.010
 Why?
Rats
1
2010
5570
0.010
 Why?
Pregnancy
1
2014
7122
0.010
 Why?
Infant
1
2014
10023
0.010
 Why?
Child
1
2014
22600
0.010
 Why?
Lee's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (354) concept(s)
_
Co-Authors Expand Description
See all (32) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)